Examples of using Eylea in English and their translations into Croatian
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Other medicines and Eylea.
Why has Eylea been approved?
Other information about Eylea.
What Eylea is and what it is used for.
What is the risk associated with Eylea?
How to prepare for Eylea treatment.
Eylea 40 mg/ml solution for injection Aflibercept.
What benefit has Eylea shown during the studies?
Eylea 40 mg/ml solution for injection in a vial Aflibercept.
Ask your doctor for advice before starting Eylea treatment.
Difference is Eylea 2 mg Q4 weeks minus Laser Control.
You will start your treatment with a series of monthly Eylea injections.
Eylea is a medicine that contains the active substance aflibercept.
At total of 67 subjects in this group received Eylea rescue treatment.
Eylea 2 mg every 8 weeks following 3 initial monthly doses N 607.
There is a theoretical risk of such events following injection of Eylea into the eye.
Eylea is given as an injection into your eye intravitreal injection.
When ready to administer Eylea, open the carton and remove the sterilised blister.
Eylea 40 mg/ml solution for injection in pre-filled syringe Aflibercept.
The Committee recommended extensions of indication for Eylea, Gilenya, Kalydeco, Opdivo, Rebetol and Vidaza.
Eylea is a solution for injection(injection) in a vial 4 mg/100 microlitres.
A doctor experienced in giving eye injections will inject Eylea into your eye under aseptic(clean and sterile) conditions.
Eylea is administered directly into the vitreous to exert local effects in the eye.
Although the systemic exposure after ocular administration is very low, Eylea should not be used during pregnancy unless the potential benefit outweighs the potential risk to the foetus.
Eylea is a solution for injection(injection) in a pre-filled syringe 3.6 mg/90 microlitres.
C Difference is Eylea group minus active control(laser) group.
As Eylea is a protein-based therapeutic, no metabolism studies have been conducted.
Using aseptic technique withdraw all of the Eylea vial contents into the syringe, keeping the vial in an upright position, slightly inclined to ease complete withdrawal.
Eylea administered at 2 mg every 8 weeks following 3 initial monthly doses(Eylea 2Q8);
With administration of Eylea, there may be some side effects affecting the eyes which are due to the injection procedure.